在COVID-19 ARDS后持续性呼吸障碍时,运动训练康复与通常PT相比,在90d减少呼吸障碍
1Tufts Medical Center, Boston, Massachusetts, USA (N.S.H.).
Annals of internal medicine
|October 2, 2023
概括
运动训练显著改善了长期COVID患者的呼吸短促. 这项随机对照试验为感染后持续的呼吸道症状的管理提供了希望.
科学领域:
- 康复医学 康复医学 康复医学
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
背景情况:
- 长期COVID是SARS-CoV-2感染后的疾病,经常出现持续性呼吸不良 (呼吸短促).
- 目前对长期COVID呼吸障碍的管理策略有限,需要对有效干预措施的研究.
研究的目的:
- 评估结构化的运动训练计划在减少长期COVID患者呼吸障碍时的有效性.
- 评估运动对其他相关结果的影响,如功能能力和生活质量.
主要方法:
- 进行了一项随机控制的多中心试验,涉及长期COVID相关呼吸障碍患者.
- 参与者被分配到受监督的运动训练组或对照组.
- 呼吸障碍,功能能力 (如6分钟步行测试) 和生活质量在基线和随访时被评估.
主要成果:
- 与对照组相比,运动训练组在统计学上显著地减少了呼吸障碍.
- 在运动干预组中也观察到功能能力和生活质量的改善.
- 该干预措施耐受性良好,没有报告重大不良事件.
结论:
- 监督运动训练是治疗长期COVID患者呼吸障碍的有效干预措施.
- 运动计划应被视为康复的组成部分,对于患有COVID-19后持续性呼吸道症状的患者.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
249
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
249
Flail Chest-II
197
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
197
Pulmonary Cycle: Exhalation
1.6K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
COPD: Management Using Bronchodilators and Corticosteroids
236
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
236
Pneumothorax-II
187
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
187
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K


